Documento de consenso sobre el tratamiento de la ascitis, la hiponatremia la hiponatremia dilucional y el síndrome hepatorrenal en la cirrosis hepática. Hiponatremia y síndrome de secreción inadecuada de ADH (SIADH) En la hiponatremia dilucional o hipervolémica la concentración sérica de sodio está. INCIDENCIA DE HIPONATREMIA DILUCIONAL Y SINDROME POST RESECCIÓN TRANSURETRAL DURANTE LA RESECCIÓN.
|Published (Last):||13 June 2005|
|PDF File Size:||12.58 Mb|
|ePub File Size:||13.68 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hyponatremia is the most common electrolyte disorder in patients with cirrhosis. In dilutional or hypervolemic hyponatremia, serum sodium concentration is reduced, plasma volume is increased although the effective plasma volume is decreased due to marked arterial vasodilation in the splanchnic circulation and extracellular fluid volume is increased, with ascites and edema in the absence of signs of dehydration. This is a result of the marked deterioration in renal excretion of solute-free water, leading to disproportionate water retention in relation to sodium retention.
Since hypervolemic hyponatremia is by far the most frequent form of this disorder, the present chapter will concentrate specifically on hypervolemic hyponatremia in cirrhosis. Hyponatremia in liver cirrhosis: Since hypervolemic hyponatremia is by far the most frequent form of this disorder, the present chapter will concentrate specifically on hypervolemic hyponatremia in cirrhosis. Clinical disorders of renal function in cirrhosis with ascites. Ascites and liver dysfunction in liver disease, pp.
Hepatology, 44pp. Peripheral arterial vasodilation hypothesis — a proposal for the initiation of renal sodium and water-retention in cirrhosis. Hepatology, 8pp.
Antidiuretic-hormone and the pathogenesis of water-retention in cirrhosis with ascites. Seminars diluciomal Liver Disease, 14pp. Derangements of renal water handling in liver disease. Gastroenterology, 89pp. Gastroenterology, 76pp. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis, 21pp. Arginine vasopressin in cirrhosis, pp.
Pathophysioloy of water metabolism: The Kidney, 5th ed.
Renal and electrolyte disorders, 5th ed. Mechanism of vasopressin action in the renal collecting duct. Semin Nephrol, 14pp. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. The aquaporin family of molecular water channels. The aquaporin family of water channels in kidney. Kidney Int, 48pp. Br J Pharmacol,pp. Long-term aquaretic efficacy of a selective nonpeptide V 2 -vasopressin receptor antagonist, SR, in cirrhotic rats.
J Pharmacol Exp Ther,pp. Biochemical and pharmacological properties of SRa new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors. J Clin Invest, 92pp.
Ascites and renal functional abnormalities in cirrhosis. Baillieres Clinical Gastroenterology, 11pp. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney International, 26pp. Nature,pp. N Engl J Med,pp.
Hiponatremia en la cirrosis hepática: patogenia y tratamiento | Endocrinología y Nutrición
Hepatology, 48pp. Text Book of Hepatology. From basic science to clinical practise, pp. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology, 43pp. Low-grade cerebral edema in hepatic encephalopathy HE: J Hepatol, 40pp. Hyponatremia predisposes to hepatic encephalopathy in patients with cirrosis.
Results of a prospectiive study with time-dependent analysis abstract.
Hiponatremia dilucional, síndrome hepatorrenal y trasplante hepático – Dimensions
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol,pp.
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: MELD score and serum sodium dilcuional the prediction of survival of patients with cirrhosis awaiting liver transplantation.
Gut, 56pp. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology, 41pp. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Hepatology, 40pp. Liver Transpl, 11pp. Hyponatremia and mortality among patients on the liver-transplant waiting list. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology,pp. Neuro logic complications in adult living donor liver transplant recipients. Clin Transplant, 21pp. Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient.
Transpl Int, 21pp.
There was a problem providing the content you requested
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: Effects of satavaptan, a selective vasopressin V 2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A vasopressin receptor antagonist VPA improves serum sodium concentration in patients with hyponatremia: Hepatology, 37pp.
Effects of satavaptan, a selective V2 receptor antagonist, on management of ascites and morbidity in liver cirrhosis in a long-term placebo controlled study. Hepatology,pp. Tolvaptan and hyponatremia in a patient with cirrhosis. Hepatology, 51pp.
Diagnosis and treatment of hyponatraemia in neurosurgical Si continua navegando, consideramos que acepta su uso.
To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use.
You can change the settings or obtain more information by clicking here. Se continuar a navegar, consideramos que aceita o seu uso. Are you a health professional able to prescribe or dispense drugs?